Skip to Main Content

Advertisement

Skip Nav Destination

The cost-effectiveness of gene therapy for severe hemophilia B: a microsimulation study from the United States perspective

Blood (2021) 138 (18): 1677–1690.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement